Regulation of NAT1 activity in modern humans by a novel phosphorylation site
Science Advances · 05.06.2026 · 12 (23)
DOI: 10.1126/sciadv.ady1666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.06.2026. Verfasst von Luise Fast und 8 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany. Hauptthemen laut MEDLINE: Arylamine N-Acetyltransferase. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swedish Research Council Formas, Max Planck Society, Swedish Brain Foundation.
Abstract (Originalsprache)
N -acetyltransferase 1 (NAT1) is an enzyme that acetylates certain drugs and carcinogens and is involved in folate metabolism. Some NAT1 variants are associated with susceptibility to cancer and birth defects. We show that while nearly all present-day humans carry a valine residue at position 149 and a serine residue at position 214, some carry the ancestral amino acids isoleucine and alanine at these positions because of gene flow from Neanderthals. Neither substitution affects enzymatic activity. However, replacing the serine residue, a known phosphorylation site, with a phosphomimetic aspartate reduces NAT1 activity by ~60%. Phosphorylation at this site may allow NAT1 to be down-regulated during pregnancy to reduce birth defect risk, while maintaining high activity in adults for xenobiotic clearance. This regulatory site is a molecular feature that differs between modern humans and Neanderthals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
- Karolinska Institutet, Stockholm, Sweden.
- Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
- Okinawa Institute of Science and Technology, Onna-son, Japan.
ORCID-Profile: Luise Fast, Mikel Lana Alberro, Richard Ågren, Stephan Riesenberg, Wieland B Huttner, Janet Kelso, Svante Pääbo, Hugo Zeberg
Förderung
- Swedish Research Council Formas
- Max Planck Society
- Swedish Brain Foundation
- Knut and Alice Wallenberg foundation
- Nomis Foundation
- Groschinskys Minnesfond
- Cornell's foundation
- Philip-Sörensen's foundation
Zitieren
APA
Fast, L., Alberro, M. L., Rakava, E., Ågren, R., Riesenberg, S., Huttner, W. B., Kelso, J., Pääbo, S., & Zeberg, H. (2026). Regulation of NAT1 activity in modern humans by a novel phosphorylation site. Science Advances, 12(23). https://doi.org/10.1126/sciadv.ady1666
Vancouver
Fast L, Alberro ML, Rakava E, Ågren R, Riesenberg S, Huttner WB, et al. Regulation of NAT1 activity in modern humans by a novel phosphorylation site. Science Advances. 2026;12(23). doi:10.1126/sciadv.ady1666
BibTeX
@article{Fast2026,
author = {Fast, Luise and Alberro, Mikel Lana and Rakava, Eva and Ågren, Richard and Riesenberg, Stephan and Huttner, Wieland B and Kelso, Janet and Pääbo, Svante and Zeberg, Hugo},
title = {Regulation of NAT1 activity in modern humans by a novel phosphorylation site},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {23},
doi = {10.1126/sciadv.ady1666}
}
EUVIMED